Association between Sleep Duration and Left Ventricular Hypertrophy for Patients with Type 2 Diabetes Mellitus

Table 3

Logistic multivariable regression analysis of the risk of LVH.

Variables	B	S.E.	Wald		OR	95% CI
Age	−0.056	0.115	0.235	0.628	0.946	0.754–1.186
BMI	−0.031	0.018	3.031	0.082	0.969	0.936–1.004
Waist	0.005	0.007	0.490	0.484	1.005	0.991–1.018
Hb	0.009	0.003	10.673	0.001	1.009	1.003–1.014
BUN	0.089	0.029	9.277	0.002	1.093	1.032–1.157
Cr	0.004	0.003	1.951	0.163	1.004	0.998–1.009
UA	0.001	0	2.304	0.129	1.001	1.000–1.002
HDL-c	−0.490	0.154	10.155	0.001	0.612	0.453–0.828
FT3	−0.005	0.057	0.007	0.934	0.995	0.890–1.114
Gender	0.012	0.110	0.011	0.915	1.012	0.815–1.256
History of HUA	−0.081	0.147	0.307	0.579	0.922	0.692–1.229
History of gout	0.107	0.309	0.121	0.728	1.113	0.608–2.039
Smoke	0.033	0.106	0.097	0.756	1.034	0.839–1.273
History of hypertension	−0.044	0.090	0.242	0.623	0.957	0.803–1.140
History of hyperlipidemia	0.124	0.087	2.042	0.153	1.132	0.955–1.343
Alcohol drinking	0.008	0.103	0.006	0.940	1.008	0.823–1.235
Enough sleep	0.446	0.085	27.723	<0.001	1.563	1.323–1.845
Sleep quality
Poor			2.863	0.239
Moderate	0.523	0.317	2.726	0.099	1.687	0.907–3.138
Good	0.451	0.310	2.122	0.145	1.570	0.856–2.883

BMI, body mass index; Hb, hemoglobin; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; HDL-c, high-density lipoprotein cholesterol; FT3, serum-free triiodothyronine; HUA, hyperuricemia.